mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.06 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.06 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.06 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.07 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |